News In Brief

July 2004
Nature Medicine;Jul2004, Vol. 10 Issue 7, p658
Academic Journal
Presents news briefs related to medicine. Endorsement by the Group of Eight (G8) industrialized nations for a global HIV vaccine enterprise; Endorsement of a Global Strategy on Diet by member states of the World Health Organization in response to the obesity epidemic; Recommendation by the American Medical Association that the U.S. Dept. of Health and Human Services create a publicly accessible registry for all U.S. clinical trials; Other briefs.


Related Articles

  • HHS Directs $1.79B in Ryan White Funds to States.  // Children & Youth Funding Report;5/22/2009, p21 

    The article reports that the U.S. Department of Health & Human Services (HHS) will release $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications. The grant will be funded through the Ryan White HIV/AIDS Program, which is...

  • Strengthening the Supply of Routinely Recommended Vaccines in the United States: A Perspective from the American Medical Association. Tan, Litjen // Clinical Infectious Diseases;3/1/2006 Supplement, Vol. 42, pS121 

    Influenza virus vaccine shortages and delays in distribution require continued collaborative efforts by all stakeholders to ensure that Healthy People 2010 goals are met. Problems with supplies of other vaccines jeopardize at-risk populations. The American Medical Association recommends that the...

  • Vaccine formulation and delivery device.  // WHO Technical Report Series;2004, Issue 927, p52 

    The article presents the section of the World Health Organization guidelines on nonclinical evaluation of vaccines concerning vaccine formulation and the delivery device. The delivery device and vaccine development whether in liquid form, capsules or powder, can have an affect on the process of...

  • HHS Still Committed To Next-Gen Anthrax Vaccine Despite Contract Termination. Biesecker, Calvin // Defense Daily;12/21/2006, p8 

    The article reports on the optimism by the U.S. Department of Health and Human Services that it can still develop a next-generation vaccine after terminating VaxGen's contract. The contract was terminated when the company failed to meet a key milestone in the program requiring it to initiate a...

  • Vaccine recalls, delays prompt discussion at NVAC meeting. Dickinson, Cara // Infectious Diseases in Children;Mar2008, Vol. 21 Issue 3, p3 

    The article reports on the need for the U.S. government and industry to work together to get vaccine supplies back on track. The recommendation was made during the National Vaccine Advisory Committee meeting that was held in Washington in February 2008. Angela K. Shen of the National Vaccine...

  • Update on vaccine-preventable diseases: Are adults in your community adequately protected? Schaffner, William // Journal of Family Practice;Apr2008, Vol. 57 Issue 4, pS1 

    The article elaborates on the significance of vaccines in preventing the onset of diseases to adults in the U.S. It reveals that successful childhood vaccination programs of health facilities in the country is a vital factor in reducing or mitigating many childhood diseases in the country but...

  • What are the Current Advances Regarding HIV Vaccines and HIV Vaccine Trials? Dhalla, Shayesta // Journal of Bioanalysis & Biomedicine;2012, Vol. 4 Issue 3, p1 

    The author discusses the current advances on HIV vaccines around the world. She offers her views on the unsuccessful STEP study, a clinical trial which tested the efficacy of an HIV vaccine. The STEP study was stopped in 2007, which revealed an increase in HIV infection for the first 18 months...

  • HHS unveils new National Vaccine Plan. Zacharyczuk, Colleen // Infectious Diseases in Children;Mar2011, Vol. 24 Issue 3, p4 

    The article reports on the introduction by the U.S. Department of Health and Human Service (HHS) of a new National Vaccine Plan, which aims to ensure enhanced access to the protective benefits of vaccines during the next ten years from 2011.

  • BARDA grants help build global flu vaccine manufacturing capacity.  // Biomedical Market Newsletter;12/20/2010, p113 

    The article reports that the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) is providing grants worth 10.4 million dollars to help the World Health Organization strengthen the ability of developing countries to produce influenza...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics